Cleared Traditional

K022783 - TL100 TENSMETER BLOOD PRESSURE MONITORI...

K022783 is the FDA 510(k) clearance for TL100 TENSMETER BLOOD PRESSURE MONITORI... by Tensys Medical, Inc.. It is a Class 2 Cardiovascular device (product code DXN) cleared through the Traditional 510(k) pathway after a 89-day FDA review.

K022783 · Tensys Medical, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2002
Decision
89d
Days
Class 2
Risk

K022783 is an FDA 510(k) clearance for the TL100 TENSMETER BLOOD PRESSURE MONITORING SYSTEM. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Tensys Medical, Inc. (San Diego, US). The FDA issued a Cleared decision on November 19, 2002 after a review of 89 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Tensys Medical, Inc. devices

Submission Details

510(k) Number K022783 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 22, 2002
Decision Date November 19, 2002
Days to Decision 89 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
36d faster than avg
Panel avg: 125d · This submission: 89d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 517
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K022783.
WELCH ALLYN VITAL SIGN MONITOR WITH MP506
K024005 · Welch Allyn, Inc. · Feb 2003
HL888
K023834 · Health & Life Co., Ltd. · Jan 2003
OMRON AUTOMATIC BLOOD PRESSURE MONITOR WITH INTELLISENSE, MODELS HEM-773, HEM-773AC
K021682 · Omron Healthcare, Inc. · Dec 2002
WELCH ALLYN VITALS SOFTWARE DEVELOPERS KIT (SDK)
K023495 · Welch Allyn, Inc. · Oct 2002
WELCH ALLYN ABPM 6100
K021756 · Welch Allyn, Inc. · Jun 2002
HL168F
K020766 · Health & Life Co., Ltd. · Apr 2002